UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline

Müller-Lissner, S; Bassotti, G; Coffin, B; Drewes, AM; Breivik, H; Eisenberg, E; Emmanuel, A; ... Morlion, B; + view all (2017) Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline. Pain Medicine , 18 (10) pp. 1837-1863. 10.1093/pm/pnw255. Green open access

[thumbnail of Emmanuel_Guideline Pain Medicine 2016-published.pdf]
Preview
Text
Emmanuel_Guideline Pain Medicine 2016-published.pdf - Published Version

Download (506kB) | Preview

Abstract

OBJECTIVE:  To formulate timely evidence-based guidelines for the management of opioid-induced bowel dysfunction. SETTING:  Constipation is a major untoward effect of opioids. Increasing prescription of opioids has correlated to increased incidence of opioid-induced constipation. However, the inhibitory effects of opioids are not confined to the colon, but also affect higher segments of the gastrointestinal tract, leading to the coining of the term "opioid-induced bowel dysfunction." METHODS:  A literature search was conducted using Medline, EMBASE, and EMBASE Classic, and the Cochrane Central Register of Controlled Trials. Predefined search terms and inclusion/exclusion criteria were used to identify and categorize relevant papers. A series of statements were formulated and justified by a comment, then labeled with the degree of agreement and their level of evidence as judged by the Strength of Recommendation Taxonomy (SORT) system. RESULTS:  From a list of 10,832 potentially relevant studies, 33 citations were identified for review. Screening the reference lists of the pertinent papers identified additional publications. Current definitions, prevalence, and mechanism of opioid-induced bowel dysfunction were reviewed, and a treatment algorithm and statements regarding patient management were developed to provide guidance on clinical best practice in the management of patients with opioid-induced constipation and opioid-induced bowel dysfunction. CONCLUSIONS:  In recent years, more insight has been gained in the pathophysiology of this "entity"; new treatment approaches have been developed, but guidelines on clinical best practice are still lacking. Current knowledge is insufficient regarding management of the opioid side effects on the upper gastrointestinal tract, but recommendations can be derived from what we know at present.

Type: Article
Title: Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1093/pm/pnw255
Publisher version: https://doi.org/10.1093/pm/pnw255
Language: English
Additional information: © 2016 American Academy of Pain Medicine. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Keywords: Constipation, Laxatives, Opioid Antagonists, Opioids, PAMORAs
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inst for Liver and Digestive Hlth
URI: https://discovery.ucl.ac.uk/id/eprint/1536572
Downloads since deposit
113Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item